338 related articles for article (PubMed ID: 17981087)
41. Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML).
Mitchell K; Steidl U
Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31451539
[TBL] [Abstract][Full Text] [Related]
42. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.
Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY
Cancer Cell; 2020 Aug; 38(2):263-278.e6. PubMed ID: 32559496
[TBL] [Abstract][Full Text] [Related]
43. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
[TBL] [Abstract][Full Text] [Related]
44. Evolution of acute myelogenous leukemia stem cell properties after treatment and progression.
Ho TC; LaMere M; Stevens BM; Ashton JM; Myers JR; O'Dwyer KM; Liesveld JL; Mendler JH; Guzman M; Morrissette JD; Zhao J; Wang ES; Wetzler M; Jordan CT; Becker MW
Blood; 2016 Sep; 128(13):1671-8. PubMed ID: 27421961
[TBL] [Abstract][Full Text] [Related]
45. Mechanisms controlling pathogenesis and survival of leukemic stem cells.
Jordan CT; Guzman ML
Oncogene; 2004 Sep; 23(43):7178-87. PubMed ID: 15378078
[TBL] [Abstract][Full Text] [Related]
46. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
Tavor S; Petit I
Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
[TBL] [Abstract][Full Text] [Related]
47. The human polynucleotide kinase/phosphatase (hPNKP) inhibitor A12B4C3 radiosensitizes human myeloid leukemia cells to Auger electron-emitting anti-CD123 ¹¹¹In-NLS-7G3 radioimmunoconjugates.
Zereshkian A; Leyton JV; Cai Z; Bergstrom D; Weinfeld M; Reilly RM
Nucl Med Biol; 2014; 41(5):377-83. PubMed ID: 24637100
[TBL] [Abstract][Full Text] [Related]
48. Leukemic stem cells as a target for eliminating acute myeloid leukemia: Gaps in translational research.
Khaldoyanidi SK; Hindoyan A; Stein A; Subklewe M
Crit Rev Oncol Hematol; 2022 Jul; 175():103710. PubMed ID: 35588936
[TBL] [Abstract][Full Text] [Related]
49. Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells.
Lee WS; Ye Z; Cheung AMS; Goh YPS; Oh HLJ; Rajarethinam R; Yeo SP; Soh MK; Chan EHL; Tan LK; Tan SY; Chuah C; Chng WJ; Connolly JE; Wang CI
Mol Cancer Ther; 2021 Sep; 20(9):1702-1712. PubMed ID: 34158344
[TBL] [Abstract][Full Text] [Related]
50. Biology and relevance of human acute myeloid leukemia stem cells.
Thomas D; Majeti R
Blood; 2017 Mar; 129(12):1577-1585. PubMed ID: 28159741
[TBL] [Abstract][Full Text] [Related]
51. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism.
Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P
Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047
[TBL] [Abstract][Full Text] [Related]
52. Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors.
Tanaka Y; Takeda R; Fukushima T; Mikami K; Tsuchiya S; Tamura M; Adachi K; Umemoto T; Asada S; Watanabe N; Morishita S; Imai M; Nagata M; Araki M; Takizawa H; Fukuyama T; Lamagna C; Masuda ES; Ito R; Goyama S; Komatsu N; Takaku T; Kitamura T
Nat Commun; 2022 Jan; 13(1):271. PubMed ID: 35022428
[TBL] [Abstract][Full Text] [Related]
53. A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor.
Li Y; Chen K; Zhou Y; Xiao Y; Deng M; Jiang Z; Ye W; Wang X; Wei X; Li J; Liang J; Zheng Z; Yao Y; Wang W; Li P; Xu B
Curr Cancer Drug Targets; 2015; 15(6):493-503. PubMed ID: 26282548
[TBL] [Abstract][Full Text] [Related]
54. Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
Ghosh J; Kapur R
Exp Hematol; 2017 Jun; 50():13-21. PubMed ID: 28342808
[TBL] [Abstract][Full Text] [Related]
55. Acute myeloid leukemia: therapeutic targeting of stem cells.
Pabon CM; Abbas HA; Konopleva M
Expert Opin Ther Targets; 2022 Jun; 26(6):547-556. PubMed ID: 35634856
[TBL] [Abstract][Full Text] [Related]
56. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.
Hansen Q; Bachas C; Smit L; Cloos J
Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375
[TBL] [Abstract][Full Text] [Related]
57. Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia.
Brunetti M; Iasenza IA; Jenner AL; Raynal NJ; Eppert K; Craig M
Leuk Res; 2024 May; 140():107485. PubMed ID: 38579483
[TBL] [Abstract][Full Text] [Related]
58. Leukemia stem cells.
Testa U
Ann Hematol; 2011 Mar; 90(3):245-71. PubMed ID: 21107841
[TBL] [Abstract][Full Text] [Related]
59. Leukemic stem cells show the way.
Bonnet D
Folia Histochem Cytobiol; 2005; 43(4):183-6. PubMed ID: 16382881
[TBL] [Abstract][Full Text] [Related]
60. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.
Dorrance AM; Neviani P; Ferenchak GJ; Huang X; Nicolet D; Maharry KS; Ozer HG; Hoellarbauer P; Khalife J; Hill EB; Yadav M; Bolon BN; Lee RJ; Lee LJ; Croce CM; Garzon R; Caligiuri MA; Bloomfield CD; Marcucci G
Leukemia; 2015 Nov; 29(11):2143-53. PubMed ID: 26055302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]